Identifying Key Structural Interactions in Heparan Sulfate-Protein Complexes
Identifying Key Structural Interactions in Heparan Sulfate-Protein Complexes
批准号:
10715985
负责人:
Kari Joanne Pederson
金额:
$16.27万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-01 至 2027-06-30
关键词:
Autoimmune DiseasesBindingBinding ProteinsBiologicalBiological ProcessBlood CirculationBlood Coagulation FactorCCL2 geneCXCL10 geneCaliforniaCalorimetryCarbohydratesCatalysisCategoriesCell AdhesionCell Adhesion MoleculesCell CommunicationCell Culture TechniquesCell surfaceCellsCharacteristicsCoagulation ProcessCollaborationsComplexCore ProteinDataDisaccharidesDisease ProgressionDockingDrug TargetingEarly identificationExtracellular MatrixFoundationsFundingFutureGlycosaminoglycansGoalsGrowth FactorHIV-1Heparitin SulfateHispanic-serving InstitutionHumanIL8 geneImmune responseInfectionInfection preventionInflammationIsotope LabelingLibrariesLife Cycle StagesLigandsMammalian CellMembrane ProteinsMethodologyModelingMolecularMolecular ConformationNuclear Magnetic ResonanceProcessProteinsProteoglycanRANTESResearchRoleSignal TransductionSpectrum AnalysisStromal Cell-Derived Factor 1Structural ModelsStructural ProteinStructureSurface Plasmon ResonanceTestingTitrationsTrainingUniversitiesVirusVirus Diseasescell growth regulationchemokinecytokinedrug developmentexperimental analysisextracellularinstitutional capacitynuclear transferprogramsprotein complexreceptorscreeningsugartissue repairundergraduate studentviral entry inhibitorvirtual
中文摘要
项目摘要
糖胺聚糖(GAG),如硫酸乙酰肝素(HS),是细胞外基质的重要组分。
所有细胞的矩阵。GAG的非凡结构多样性使它们能够与各种各样的生物分子相互作用。
生物分子,但主要是蛋白质,以调节生物过程,如细胞粘附,组织
修复、凝血和免疫反应等。此外,一些不同的病毒,
包括HIV-1,通过与细胞表面GAG结合来启动细胞感染。不幸的是,
GAG序列中潜在的结合基序使得相关序列的鉴定具有挑战性。在
特别是硫酸乙酰肝素(HS)是结构上最多样化的,具有16种独特的二糖构型
和256种独特的四糖构型。近年来取得了重大进展,
合成HS寡聚体的文库,允许HS蛋白的详细实验结构研究
配合物了解这些相互作用的结构基础是药物开发和HS的关键
迄今为止,结合蛋白-HS(HSBP-HS)相互作用的研究要么是非结构性的,要么是计算性的。
该项目的总体目标是利用这些最近开发的合成HS库和基于NMR的
结构模型,以确定关键的相互作用。HIV-1 p17将用于初步研究,因为它非常
在HIV-1生命周期的许多阶段都很重要。已知硫酸乙酰肝素受体影响生长
因子信号传导、细胞粘附和人类细胞上的酶催化。因此,这种相互作用可以是以下之一:
HIV-1感染者疾病进展的决定因素。在目标1中,合成HS的文库
将筛选四糖与人类免疫缺陷病毒1型(HIV-1)p17蛋白的结合,
鉴定优选结合寡聚体的序列特异性HS特征。在目标2中,HSBP-HS
将通过核磁共振(NMR)研究强结合序列和弱结合序列的复合物
模拟复合物的结构,并确定未来药物开发的关键相互作用。后
方法学建立后,HS结合趋化因子将在目标3中筛选,以确定合适的靶点,
未来的NMR研究
英文摘要
Project Summary
Glycosaminoglycans (GAGs), such as heparan sulfate (HS), are important components of the extracellular
matrix of all cells. The extraordinary structural diversity of GAGs enables them to interact with a wide variety of
biological molecules, but primarily proteins, to modulate biological processes, such as cell adhesion, tissue
repair, coagulation, and immune response, among many others. Additionally, a number of different viruses,
including HIV-1, initiate infection of cells by binding to cell surface GAGs. Unfortunately, the diversity of
potential binding motifs in GAG sequences has made identification of relevant sequences challenging. In
particular, heparan sulfate (HS) is the most structurally diverse, with sixteen unique disaccharide configurations
and 256 unique tetrasaccharide configurations. Significant progress has been made in recent years developing
libraries of synthetic HS oligomers, allowing for detailed experimental structural studies of HS-protein
complexes. Understanding the structural basis of these interactions is key to drug development and the HS
binding protein-HS (HSBP-HS) interaction studies to date have been either non-structural or computational.
The overall goal of this project is to utilize these recently developed synthetic HS libraries and NMR-based
structural models to identify key interactions. HIV-1 p17 will be used for initial studies because it is very
important in many stages of the life cycle of HIV-1. Heparan sulfate receptors are known to influence growth
factor signaling, cell adhesion, and enzymatic catalysis on human cells. Thus, this interaction may be one of
the deciding factors for disease progression in humans infected with HIV-1. In Aim 1, a library of synthetic HS
tetrasaccharides will be screened for binding to human immunodeficiency virus type 1 (HIV-1) p17 protein to
identify the sequence-specific HS characteristics of the preferred binding oligomers. In Aim 2, the HSBP-HS
complexes of both strong and weak binding sequences will be studied via nuclear magnetic resonance (NMR)
to model the structure of the complex and identify key interactions for future drug development. After the
methodology is established, HS-binding chemokines will be screened in Aim 3 to identify suitable targets for
future NMR studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NMR studies of vaccinia virus interferon binding protein: interactions with GAGs
-
批准号:8649447
-
项目类别:
-
资助金额:$5.51万
-
财政年份:2014
-
负责人:Kari Joanne Pederson
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: